LAL Solace

Clinical Trials » Clinical Trials Resource Center

Zoloft (sertraline HCl)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved October 1997

Specific Treatments:

panic disorder/obsessive compulsive disorder

General Information

The U.S. Food and Drug Administration (FDA) approved Zoloft for the treatment of obsessive-compulsive disorder in children ages 6 to17 years of age. Zoloft has already been approved for treatment of panic disorder and obsessive-compulsive disorder in adults.